Código QR

The Landscape of MET Exon 14 Skipping Mutations in Patients With Lung Cancer Identified by Next-Generation Sequencing

Introduction: MET exon 14 (METex14) skipping mutations are observed in approximately 0.9% to 4% of patients with NSCLC. This study aimed to compare the detection rates of METex14 skipping in Chinese patients with lung cancer using DNA-based next-generation sequencing (NGS) with capture-based library...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jia Liao, MD, Song Wu, MD, Yi Min, MD, Yiran Li, MD, Yuanhang Nie, MD, Quwen Chen, MD, Zhiliang Mao, MD, Qinglan Zong, MS, Ning Gao, MS, Ding Zhang, PhD, Weiquan Liang, MD
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2025-07-01
Colección:JTO Clinical and Research Reports
Materias:
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2666364325000426
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!